However, despite representing a growing health care challenge, alpha thalassemia has drawn significantly less attention," said senior author Stefano Rivella, Ph.D., a research faculty member in ...

Considering taking supplements to treat beta thalassemia? Below is a list of common natural remedies used to treat or reduce the symptoms of beta thalassemia. Follow the links to read common uses ...

Patients with transfusion-dependent β-thalassemia experienced 14.8 hospitalizations annually, according to the findings.

Early data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such ...

For the freshest news, join The Borneo Post's Telegram Channel and The Borneo Post on Newswav. Previous ArticleMinimum wage: Sabah timber industries call for moratorium ...

Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

Topline Data from 52-week Phase 3 Study Expected in Late 2025 –CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, ...

Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET. Company Participants. Chris Taylor - Vice President, Investor Relations and ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

Q3 2024 Earnings Call Transcript October 31, 2024 Operator: Good morning, and welcome to Agios’ Third Quarter 2024 Conference Call. [Operator Instructions] Please be advised that today’s call is being ...

Topline Data from 52-week Phase 3 Study Expected in Late 2025 - CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyru ...